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Abstract
LSVT-LOUD® has been shown to improve phonatory quality in patients with PD.
Previous studies have shown an increase in vowel space area following treatment, but questions
remain regarding possible methodological issues in interaction with phonatory factors. This
study addressed these questions by comparing multiple formant measurement methods and
vowel space metrics. Ten participants were recorded on two separate days before and after
treatment. Formants were measured using a human-guided reference (dubbed ‘HGIM’), LPC,
and two forms of a cepstrally-liftered spectrum. Multiple vowel space metrics including the
vowel articulation index, F2i/F2u, area of the vowel quadrilateral, and vowel formant dispersion
utilized both lax and corner vowels to explore vowel space changes. Analysis revealed no
significant change in vowel space following LSVT. High variability in LPC with a fixed
coefficient was noted. These results do not support previous claims of increased vowel space but
suggest that formant measurement methods may influence results.
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The Effect of Formant Measurement Methods on Vowel Space in Patients with Parkinson’s
Disease Before and After Voice Treatment
Parkinson’s disease has a serious impact on society. Lee Silverman Voice Treatment
(LSVT) is known to improve phonatory quality and intelligibility. Previous studies seeking to
explain increased intelligibility in terms of improved articulation fail to take into account the
effect of phonatory factors on measures of articulation, such as vowel space area. This thesis
will explain how phonatory factors influence acoustic measures of formants, and in turn vowel
space, using a variety of formant measurement methods and vowel space area metrics.
Parkinsonism refers to a group of disorder that are characterized by resting tremors,
rigidity, akinesia, and postural instability (Darley, Aronson, & Brown, 1969; Yorkston,
Beukelman, Strand, & Hakel, 2010). It includes idiopathic Parkinson’s disease, secondary
parkinsonism, and Parkinson’s plus-syndromes (Adams & Dykstra, 2009; Ben-Shlomo &
Sieradzan, 1995; Duffy, 2013; Yorkston et al., 2010). Idiopathic Parkinson’s disease (PD) has
no known cause but is characterized by basal ganglia dysfunction related to the loss of
dopamine-producing cells known as dopaminergic neurons (Duffy, 2013; Yorkston et al.,
2010). Loss of these cells and consequent effects on basal ganglia dysfunction leads to
involuntary movements as well as decreased amplitude and force of movements (Duffy,
2013). Secondary parkinsonisms are disorders that share the symptoms of PD but have a known
cause such as strokes, toxic-metabolic conditions, certain infections, or repeated head trauma
(Darley et al., 1969; Duffy, 2013; Yorkston et al., 2010). Parkinson’s-plus syndromes have the
same symptoms as PD but include other symptoms; examples of Parkinson’s-plus syndromes
include multiple system atrophy, progressive supranuclear palsy (PSP), corticobasal
degeneration, and striatonigral degeneration (Duffy, 2013; Yorkston et al. 2010). The focus of
1

this thesis is idiopathic Parkinson’s disease.
Incidence and Impact on Society
In a review on the epidemiology of PD, de Lau and Breteler (2006) noted that
“Parkinson’s disease (PD) is the second most common neurodegenerative after Alzheimer’s and
is expected to impose an increasing social and economic burden on societies as populations age”
(p. 525). The incidence of PD rises with age, with an incidence of approximately 93.1 in
100,000 people between the ages of 70 and 79 versus an incidence of 17.4 in 100,000 people
between the ages of 50 and 59 (Lees, Hardy & Revesz, 2009). Some studies indicate that men
are at a greater risk of developing PD than women, though differences have been noted across
studies (de Lau & Breteler, 2006; Lees et al., 2009). Though age is considered a major risk
factor, it should be noted that 10% of the people with PD are younger than 45 years of age (Lees
et al., 2009). The median age of onset is 60 years of age and the average duration of survival
after diagnosis is 15 years (Duffy, 2013; Lees et al., 2009). Among the most prominent features
of PD is the marked change in speech and voice over the progression of the disease, which can
have a profound impact on quality of life of patients living with PD.
Hypokinetic Dysarthria and PD
Hypokinetic dysarthria (HKD) is characterized by a decreased amplitude and force of
speech movements (Adams & Dykstra, 2009; Duffy, 2013). HKD is most often associated with
PD and is estimated to occur in 60 to 80% of patients diagnosed with PD (Adams & Dykstra,
2009; Duffy, 2013). It affects all levels of speech, including respiration, phonation, resonance,
and articulation, but can be especially detrimental to voice, articulation and prosody (Duffy,
2013).
Changes in respiration. Changes in respiration are most often attributed to stiffening of

2

the respiratory musculature, resulting in reduced vital capacity and amplitude of chest wall
movements, as well as irregular breathing patterns (Adams & Dykstra, 2009; Duffy, 2013; Gentil
& Pollak, 1995). Numerous studies have found that the maximum sustained phonation of
patients with PD was shorter than normal controls, though some studies did not find a significant
difference between these groups (Adams & Dykstra, 2009; Canter, 1965; Duffy, 2013; Gentil &
Pollak, 1995). Adams and Dykstra (2009) suggested several reasons for this inconsistency,
including differences severity level, symptoms profile, testing procedures, and amount of
practice the participants received from study to study. In addition to maximum sustained
phonation, in his review of the literature Duffy (2013) found:
…reduced airflow volume during vowel prolongation, fewer syllables per breath group,
shorter utterance length, use of greater than average percentage of vital capacity per
syllable, increased inspiratory duration during extemporaneous speech, and increased
breath groups during reading have been documented in some patients with parkinsonisms
and presumed hypokinetic dysarthria. (p. 175)
Reduced respiratory capacity and efficiency can have a direct effect on phonation and perceptual
features that are a hallmark of HKD as associated with PD.
Changes in phonation. One of the most common perceptual features of PD is reduced
loudness. The physical correlate of loudness, intensity, has been examined in many studies with
varying results. According to Adams and Dykstra (2009), some studies found a decrease in
average intensity to corroborate a perceived decrease in loudness while other studies did not
support this conclusion. For example, Adams et al. (2006) found a decreased average intensity
in conversational speech, sentence imitation, and maximum intensity. On the other hand, Canter
(1965) found no significant difference in average sound pressure level (SPL) between
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participants with PD and normal controls when they were instructed to repeat the syllable “no” at
an “average” loudness level. Interestingly, participants with PD demonstrated significantly
lower SPL for the “loud” and “shouted” conditions. In another study, Canter (1963) found no
significant difference in mean peak SPL between participants with PD and normal controls
during oral reading. In a study by Dromey (2003), participants with PD differed significantly
from normal controls in the vowel phonation task but not in the reading or monologue task. In
his review of the literature, Duffy (2013) stated that measures of intensity “generally document
reduced vocal intensity” (p. 175). Clearly, there are confounding factors such as the definition of
average intensity and the effects of speech task on SPL. It is also possible that intensity is not a
perfect physical correlate of the perceptual feature loudness. Additionally, it must be considered
that the variation in physical results from perceptual observations may be due to the
unnaturalness of the task or the environment in which the data is collected.
Though it is not a typically noted perceptual change, many studies have reported a higher
fundamental frequency in participants with PD than normal controls (Adams & Dykstra, 2009;
Canter, 1963; Duffy, 2013; Dromey, 2003). Adams and Dykstra (2009) and Duffy (2013) in
their reviews of HKD, also documented studies that found no change. Interestingly, Dromey
(2003) found a significant difference in fundamental frequency between participants with PD and
age-matched neurologically normal controls only during the monologue task and not during the
vowel phonation or reading task. Overall, however, studies support the conclusion that patients
with PD have a significantly higher F0 than normal controls but also that it may be task-specific.
Changes in voice. Changes in vocal quality is a prominent feature of HKD. Dromey
(2003) found a higher perceptual rating of dysphonia in patients with PD than in neurologically
normal age-matched controls. Dromey (2003) also found that phonatory function was perceived
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as more impaired than articulation. In the same vein, Logemann, Fisher, Boshes, and Blonsky
(1978) found that 89% of the PD patients in their sample were judged to have a laryngeal (voice)
disorder, which was defined as any of the following: “breathiness, roughness, hoarseness,
tremulousness, reduced pitch range, and a modal speaking pitch inappropriate to the patient’s age
and sex” (p. 49). Of the patients displaying a laryngeal dysfunction, 45% were judged to have a
voice disorder in the absence of any articulatory deficit, while all but one patient with an
articulation deficit was judged to have a co-occurring laryngeal dysfunction (Logemann et al.,
1978). The vocal quality of patients with PD has often been described as breathy and harsh
(Adams & Dykstra, 2009; Darley et al, 1969,). In the study by Logemann et al. (1978), 45% of
the patients were perceived as hoarse, 29% as rough, and 15% as breathy. This discrepancy in
perceptual judgement is likely due to the fact that the terms used to describe voice disorders are
ill-defined and often vary from person to person and study to study. Acoustic characteristics that
correlate with perceived vocal qualities have proved elusive. Some acoustic qualities that have
been successfully ascribed to perceptual characteristics include the correlation between steeper
spectral tilt and breathiness (de Krom, 1995), which has been observed in patients with PD
(Dromey, 2003). Elevated signal-to noise ratios has been correlated to both breathiness and
roughness (de Krom, 1995) and has been inconsistently noted in acoustic studies of patients with
PD (Adams & Dykstra, 2009).
Changes in prosody. Prosodic abnormalities that have been noted in the PD population
include monopitch, monoloudness, reduced stress, short phrases, variable rate, and short rushes
of speech (Adams & Dykstra, 2009; Darley et al., 1969; Gentil & Pollak, 1995; Kent &
Rosenbeck, 1982). Darkins, Fromkin, and Benson (1988) studied whether the aprosody noted in
the speech of individuals with PD was the result of a language impairment rather than a motor
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impairment by asking participants to differentiate between noun compounds (e.g. greenhouse)
and noun phrases (e.g. green house) both receptively and expressively. The subjects with PD did
not differentiate between the two categories expressively, failing to distinguish between the two
categories in terms of pause or pitch. However, they did not differ from normal controls in terms
of prosodic comprehension, suggesting that the prosodic abnormalities shown by patients with
PD is the product of a disordered speech mechanism, rather than due to any kind of language
impairment. Acceleration of speech rate is one of the features that distinguishes HKD from the
other dysarthrias. Kent and Rosenbeck (1982) suggested that “the perception of ‘short rushes of
speech’ or ‘accelerated speech’ might be based not so much on actual increases in the rate of
articulatory events as on reductions in the range of articulatory movements” (p. 274). This was
first posited by Netsell, Daniel, and Celesia (1975), who attributed this undershoot to muscle
rigidity, stating, “The speaker might excite the rigid musculature with normally timed neural
control signals for voluntary movements…only to have the speech articulators fail to reach the
necessary position for production of a particular speech sound before beginning the movement
for the following sound” (p. 170). Thus there appears to be an interplay between articulation and
prosody. Prosodic abnormalities are considered one of the most characteristic features of HKD
associated with PD.
Changes in articulation: Consonants. Indistinct articulation has long been noted as a
feature of PD. Attempts to specify the acoustic and phonetic changes that lead to the perception
has revealed a variety of factors. The most prominent changes have been noted in consonants.
Logemann et al. (1978) studied the phonemes in error and concluded that place and manner of
obstruent consonants was affected while voicing was not. Gentil and Pollak (1995) attributed
articulatory consonant “blurring” to articulatory undershoot due to reduced excursion of the
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articulators as a result of muscular rigidity that is an intrinsic feature of PD. This is supported by
previous studies that have found that loss of phonemic identity is due to incomplete closure of
the articulators (Ackerman & Ziegler, 1991; Darley et al., 1969). This is especially apparent in
the spirantization of stops, where stop consonants are produced with increased frication (Adams
& Dykstra, 2009; Canter, 1965; Kent & Rosenbeck, 1982; Logemann & Fisher, 1981).
Logemann and Fisher (1981) found that the stop-plosives /k/ and /g/ were the most commonly
misarticulated stop consonants, followed by /ʧ/ and /ʤ/, /p/ and /b/, and /t/ and /d/ respectively.
Logemann et al. (1978) suggest that deterioration of speech and voice begins in the laryngeal
area as hoarseness or breathiness and proceeds anteriorly, first affecting phonemes produced
with the back of tongue, then anterior lingual placements and finally labial articulations. This
progression is supported by Logemann and Fisher’s (1981) later inventory of misarticulated
phonemes with the exception of /t/ and /d/, which one would expect to be the third most
commonly misarticulated pair. It is possible, however, that the teeth act as an additional barrier
to mask the reduced degree of closure achieved at the alveolar ridge. Studies have also noted
that fricatives have less frication energy as a result of less forceful or turbulent airflow, which
also can be attributed to a reduced degree of closure (Adams & Dykstra, 2009; Logemann &
Fisher, 1981). Changes in articulation can be attributed to more than just changes in manner.
Forrest, Weismer, and Turner (1988) found that PD patients had a longer voice onset time (VOT)
compared to normal elderly controls. VOT is the time between the burst, or initial opening of
the articulators, of a voiced stop consonant and the onset of voicing. Changes in VOT can result
in distortion of the target phoneme.
Changes in articulation: Vowels. Impairment of vowel articulation in hypokinetic
dysarthria has not been widely studied and is generally judged to be less impaired than

7

consonants (Adams & Dykstra, 2009). Similar to the issues experienced in consonant
articulation, it has been posited that vowel articulation may be impaired due to articulatory
undershoot (Skodda, Visser, & Schlegel, 2011). A general reduction in vowel space associated
with PD has been noted (Adams & Dykstra, 2009) though effects may be subtle and have not
been consistently documented in all patients with PD. Various forms of vowel space have been
used in an attempt to document this theorized reduction in vowel space with varying results
(Sapir, Ramig, Spielman & Fox, 2010): vowel space metrics will be detailed further in
Measuring Articulation: Vowel Space Area and Table 1 (see Appendix). Skodda et al. (2011)
found a significant reduction in vowel space area in males with PD during sentence reading.
Their study utilized triangular vowel space area (tVSA), calculated using the corner vowels /i/,
/u/, and /ɑ/. Sapir et al. (2010) developed the formant centralization ratio (FCR), which also uses
the corner vowel /i/, /u/, and /ɑ/. Their study found a significant reduction in FCR between
participants with PD and age-matched normal controls; the study also found that FCR sensitively
differentiated between dysarthric participants and healthy participants (Sapir et al., 2010). The
variability between studies may be due to methodological differences, but it should also be
considered that a metric that is sensitive enough to detect PD’s subtle effects on vowel
articulation has not yet been developed.
Most studies of vowel articulation have focused on the corner vowels /i/, /u/, and /ɑ/.
Tjaden, Rivera, Wilding, and Turner (2005) examined changes in vowel space using the lax
vowels /ɪ/, /ʊ/, and /ɛ/. The study found no difference between participants with PD and
neurologically normal controls when reading at their habitual rate (Tjaden et al., 2005). This is
not surprising considering these lax vowels require less tongue excursion than the corner vowels.
Vowel space is not the only available measure of vowel articulation. Forrest et al. (1989) found
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reduced formant transitions in segments /aɪ/, /ijə/ and /ɪl/, which can affect the intelligibility of
speech.
Changes in intelligibility. Decreases in intelligibility have been commonly reported in
PD (Anand & Stepp, 2015; Cannito, Suiter, Beverly, Chorna, Wolf, & Pfeiffer, 2012; Cannito,
Suiter, Wolf, Chorna, Beverly, & Watkins, 2008; Duffy, 2013; Neel, 2009). According to a 10year review of patients with PD by Duffy (2013) at the Mayo Clinic, 79% of patients had
reduced intelligibility. Intelligibility has been found to worsen with the progression of PD
(Anand & Stepp, 2015). The various speech deficits associated with PD impact intelligibility to
varying degrees, making it difficult to determine exactly what element would best be targeted by
therapeutic intervention. Anand and Stepp (2015) investigated the effect of monopitch on
intelligibility. They found that the impact of monopitch on intelligibility was variable, with a
greater impact on participants with moderate dysarthria than mild or severe dysarthria. Reduced
loudness is a common complaint in PD, and many successful therapeutic interventions focus on
increasing loudness. Neel (2009) investigated whether simply increasing the intensity of the
speech signal without any other acoustic changes was as effective as loud speech. She found that
amplified speech was significantly more intelligible than habitual speech; however loud speech,
which is accompanied by other acoustic changes to the voice, was more intelligible than
amplified speech.
Changes in vowel space area have also been implicated in changes in intelligibility.
According to Weismer, Jeng, Laures, Kent, and Kent (2001), “The direction of the acoustic
vowel space effect is logical because a relatively compressed space would suggest reduced
acoustic contrast among vowels, with a loss in word distinctiveness in either single words or
sentences” (p. 17). In their study of vowel space and intelligibility in participants with
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amyotrophic lateral sclerosis (ALS) and PD, Weismer et al. (2001) found that acoustic vowel
space was highly correlated with single word and sentence intelligibility. However, in the same
study, Weismer et al. found that participants with ALS had a smaller vowel space but greater
intelligibility at sentence level compared to participants with PD, suggesting that there is more
than vowel space at play. According to a review of the literature by Kim, Hasegawa-Johnson,
and Perlman (2010), the strength of the relationship between vowel space area and intelligibility
has ranged from 0 to 71% across studies of different speech impairments. Neel (2008) found
that vowel space area accounted for 9 to 12% of the variance in intelligibility in normal speakers.
In their study of children with dysarthria, Higgins and Hodge (2002) found that vowel space area
accounted for 53% of variance in single words and 41% of variance in sentences. Turner,
Tjaden, and Weismer (1995) found that vowel space area accounted for 45% of variance in
intelligibility in speakers with ALS. The effect of vowel space area on intelligibility in speakers
with PD has also been investigated with vowel space area accounting for 6 to 46% of
intelligibility (Tjaden & Wilding, 2004; Weismer, et al., 2001). In a study by McRae, Tjaden,
and Schoonings (2002), vowel space area accounted for 13% of variance in perception of
severity, with smaller vowel space area being associated with a greater perception of severity.
These varying results suggest that vowel space area, like other aspects of speech, plays a role in
intelligibility but is not the sole, or even most important component. Turner, Tjaden, and
Wilding (1995) suggest that perhaps vowel space area is more predictive of intelligibility in
patients who are less than 70% intelligible, which may explain why the role of vowel space area
varies between conditions and individuals. Intelligibility is a complex, multifactorial feature and
contributing factors should be considered individually for each individual.
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Treatments for Dysarthria Associated with Parkinson’s Disease
There are a variety of treatment options available for patients with PD suffering from
speech and voice disorders. According to Trail et al. (2005), “Current treatments for speech and
voice disorders in people with PD consist of medical therapies, surgical procedures, behavioral
speech therapy, or a combination thereof” (p. 208). Medical and surgical interventions alone
have been shown to have a limited effect on voice (Fox, Morrison, Ramig, & Sapir, 2002;
Ramig, Fox, & Sapir, 2004; Trail et al., 2005; Yorkston & Beukelman, 2010). Trail et al. (2005)
concluded in their review of current speech treatments for PD that “At this time, a combination
of medical therapy (e.g., optimal medication) with behavioral speech therapy appears to offer the
greatest improvement for speech dysfunction” (p. 208). The following paragraphs provide a
brief review of medical, surgical, and behavioral interventions for speech disorders associated
with PD.
Medical treatments. One of the most common medical treatments for PD is the use of
levodopa, which helps boost dopamine levels in the brain. Though it has been shown to have
positive effects for limb movement and function, it has a less significant effect on speech (Trail
et al., 2005). Biary, Pimental and Langenberg’s study (as cited in Trail et al., 2005) found that
the use of clonazepam improved some aspects of speech including short rushes of speech,
imprecise consonant and inappropriate silences. However, their study showed little
improvement in voice quality or low pitch. Though medical treatments have some utility in
improving speech and voice, medication alone is not effective.
Surgical treatments. Various surgical treatments have been used in the treatment of
speech and voice disorders associated with PD. Pallidotomy and thalamotomy are two common
surgical procedures that have been historically used to treat the motor symptoms of PD. They
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typically have no effect on speech or can actually lead to a decline in speech function (Farrell,
Theodoros, Ward, Hall, & Silburn, 2005; Tarazi, Sahli, Wolny, & Mousa, 2014; Trail et al.,
2005). The use of deep brain stimulation has been shown to improve motor symptoms but not
speech and is often associated with worsening intelligibility (Tarazi et al., 2014; Trail et al.,
2005). Collagen injection in the vocal folds temporarily improves hypophonia but has no effect
on any other aspect of speech (Trail et al., 2005). Overall, surgical treatment is most effective
for the motor symptoms of PD and is not meant to be a speech intervention.
Behavioral therapy. Of all the intervention techniques, behavioral therapy has shown
the most promise in treating speech and voice disorders associated with PD. According to
Adams and Dykstra (2009), the main points of focus of behavioral therapy are “(1) increasing
speech intensity, (2) improving speech prosody (i.e., monotonous/monoloud speech), (3)
reducing rapid speech, and (4) increasing articulatory mobility and precision” (p. 174). A variety
of strategies have been used to achieve these goals. Ramig, Countryman, Thompson, and Horii
(1995) studied the effect of increasing respiratory effort on reducing hypophonia. Increase
respiratory effort was targeted using maximum inhalation and exhalation tasks, maximum
duration of voiceless continuants /s/ and /f/ and sustained intraoral pressure. The participants
showed improvements in some aspects of speech such as SPL during reading and perceptual selfratings of loudness in females, and pause duration during reading for male and female
participants. Dromey (2000) compared the effect of increasing vocal loudness versus
hyperarticulation on lip kinematics in patients with PD. His study found that both methods were
effective in increasing lip displacements, intensity, and lip velocity, though the loudness therapy
showed a greater increase in loudness and hyperarticulation therapy showed a greater increase in
oral movements.
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Biofeedback and prosthetic devices. Biofeedback can be used during behavioral
therapy to provide the patient with information about pitch variation, speech loudness, and
speech rate. Adams and Dykstra (2009) in their review of the use of biofeedback as part of
behavioral therapy concluded that
(1) improvement in the speech of PD patients can be achieved through biofeedback
therapy, (2) these improvements can be measured in the clinical setting through the use of
both perceptual and acoustic procedures, and (3) improvements achieved through
behavioral therapy plus biofeedback are greater than improvements achieved with
behavioral therapy alone. (p. 176)
They also concluded that little carryover occurs with the use of biofeedback, though it should be
noted that there are currently few studies evaluating carryover following therapy using
biofeedback.
The use of prosthetic devices in aiding carryover has been sparsely studied for patients
with PD. Adams and Dykstra (2009) suggest the use of a voice-activated masker to provide
background noise for patients with hypophonia. Though this has not been studied, it is supported
by a study by Adams et al. (2006) that found that patients with PD increase their loudness to
compensate for background noise. Other devices that have been shown to have some long-term
success include the use of delayed auditory feedback (DAF), voice amplification devices, and
pacing boards (Trail et al., 2005). Pacing strategies such as pacing boards or finger tapping have
been shown to slow rate while DAF has been shown to slow rate and improve intelligibility
(Adams & Dykstra, 2009).
Lee Silverman Voice Treatment (LSVT-LOUD®). LSVT is currently considered the
gold standard of behavioral treatment for HKD associated with PD and has been intensively
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studied over the last two decades. According to Fox et al. (2002), LSVT hinges on five
concepts:
(a) exclusive focus on voice (specifically vocal loudness), (b) stimulation of high-effort
productions with multiple repetitions, (c) intensive delivery of treatment (4 individual
sessions a week for 4 weeks, 16 sessions in one month), (d) enhancing sensory awareness
of increased vocal loudness and effort (calibration), and (e) quantification of behaviors.
(p. 112)
Though pitch variability is also targeted, the primary therapeutic target is increased vocal
loudness, which, according to Trail et al. (2005), “acts as a ‘trigger’ to increase vocal effort and
coordination across the speech production system” (p. 213). The program consists of intensive
treatment for 50 to 60 min four times per week for one month. Tasks completed during therapy
include maximum sustained vowel phonation with a constant level of loudness and steadiness,
and pitch exercises, including having the patient modulate their voice from their habitual pitch to
their highest pitch as well as their habitual to lowest pitch. Daily homework is also an important
aspect of the program. Though LSVT was designed for and is primarily used with PD, its use
has been studied with other populations such as adults with ataxic dysarthria (Sapir et al., 2003),
parkinsonian plus syndromes (Countryman, Ramig, & Pawlas, 1994), multiple sclerosis, aging
voices, cerebellar ataxia (Fox, Ramig, Ciucci, Sapir, McFarland, & Farley, 2006) and children
with cerebral palsy and Down syndrome (Fox et al., 2006).
Therapeutic Changes Through LSVT
LSVT has been reported to produce global changes in speech and voice, meaning that the
therapeutic targets have been shown to produce changes outside of the intended effects. Though
LSVT targets both increased loudness and pitch variability, increased loudness has been
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implicated as the primary impetus for changes in non-targeted areas. Changes have been noted in
the areas of phonation, articulation, and prosody. Some phonatory changes include
improvements in SPL, voice quality, and vocal fold function, while articulatory improvements
have largely been supported by increased vowel space. Increased facial expression and
improved intonation have also been noted (Fox et al., 2002; Fox et al., 2006). In addition to
communicative function, LSVT has also been shown to improve swallowing in dysphagic
patients (Fox et al., 2002; Fox et al., 2006).
How this carryover into various other oral and laryngeal functions takes place is not well
understood. In their paper outlining the LSVT approach and presenting preliminary efficacy
data, Ramig, Bonitati, Lemke, and Horii (1994) stated that “Therapy techniques were designed to
improve perceptual characteristics of voice by targeting the hypothesized underlying physical
pathology” (p. 193). Fox et al. (2002) expands on this concluding:
…LSVT may affect speech production at two levels. (a) Increased loudness can improve
vocal fold closure and enhance the phonatory source, consistent with improving the
carrier in the classic engineering concept of signal transmission...(b) Increased loudness
may stimulate increased effort and coordination across the respiratory, laryngeal, and
orofacial systems. (p. 114)
The surprisingly widespread effects of this singular target have been the subject of a variety of
studies exploring the effects of LSVT on respiration, phonation, articulation, intelligibility and
prosody.
Changes in respiration. Improvements in respiration to support speech have been
documented in various studies. Though studies have not shown an increase in vital capacity,
several studies have shown an increase in the duration of vowel phonation from pre to post
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LSVT (Ramig et al., 1994; Ramig et al., 1995). This suggests improved control over and more
efficient use of air flow following treatment. This is supported by Ramig and Dromey’s (1996)
study, which found increased subglottal air pressure and improved maximum flow declination
rate. Respiratory improvements provide a foundation for improved phonation.
Changes in phonation. Various changes have been noted in patients with HKD
following treatment with LSVT including changes in SPL, fundamental frequency, and voice
quality. Increased loudness (of which SPL is the acoustic dimension) has been moderately
supported both perceptually and acoustically. Studies of perceptual ratings of loudness are not
consistent with one another but overall suggest an improvement in loudness. Ramig et al. (1994)
found that participants rated themselves as having a significant increase in loudness while ratings
by family members did not show a significant improvement in loudness. Both familiar and
unfamiliar clinicians, however, rated participants as having significantly improved loudness. In
contrast, Ramig et al. (1995) found only male participants rated themselves as having improved
in loudness, while in an assessment completed by the family, both male and female participants
were rated as having improved loudness. Acoustic studies have shown increased SPL as
measured in decibels (dB) across tasks including sustained vowel phonation (Cannito et al.,
2012; Ramig et al., 1995), reading and conversation (Ramig et al., 1995). The difference
between perceptual increases in loudness versus acoustic increases in intensity may at first cast
doubt on whether the measured acoustic changes reach beyond statistical significance into
clinical significance. However, this issue echoes the ambiguous results of studies into decreased
loudness/intensity in patients with PD discussed previously (see Hypokinetic Dysarthria and PD:
Changes in Phonation), reinforcing the idea that perception of loudness is a multifaceted issue
and may be confounded with other acoustic factors besides intensity. The subjective nature of
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loudness ratings may also play a part in these variable results.
Fundamental frequency has also shown improvement over the course of treatment, both
in terms of mean and habitual fundamental frequency as well as fundamental frequency
variability and range. Ramig et al. (1994) found that participants showed improved mean
fundamental frequency only during reading, while a study by Ramig et al. (1995) found
increased habitual fundamental frequency across all tasks, including sustained phonation,
reading, and monologue. Ramig et al. (1994) also noted an increase in maximum fundamental
frequency range as was as fundamental frequency variability during reading. This was supported
by a later study by Ramig et al. (1995) that also showed increased variability during reading and
monologue.
Voice quality, a prominent feature in patients with PD, has been examined both
perceptually and acoustically before and after treatment. Ramig et al. (1995) found an
improvement in self-ratings of hoarseness in participants following treatment. Cannito et al.
(2006) examined the acoustic correlates of voice quality and observed changes from pre to post
therapy. Their study found a decrease in harmonic amplitude differences as a result of an
increase in the second harmonic (H2), first formant (F1), second formant (F2), and third formant
(F3). Energy in the upper harmonics, which was reduced prior to treatment, increased. Taken
together, these results indicate an improvement in spectral tilt (i.e., reduced tilt), supporting a
perceptual decrease in breathiness. This is supported by visualization of improved true vocal
fold closure seen on videostroboscopy (Smith, Ramig, Dromey, Perez, & Samandari, 1994).
Changes in intelligibility. Of practical interest are changes in intelligibility that take
place in the course of treatment. Subjective results include ratings of intelligibility by the
participant, the participant’s family and the clinician. Though results of individual studies have
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varied, evidence suggests a significant increase in intelligibility as judged by family members,
familiar and unfamiliar clinicians, and the participants themselves (Ramig et al., 1994; Ramig et
al., 1995). Objective measures of intelligibility have also been utilized. In a study of a single
speaker, Cannito et al. (2008) found a statistically significant increase in the percentage of words
understood by unfamiliar listeners from pre to post LSVT. This study was later replicated by
Cannito et al. (2012) with a larger group of participants; six out of the eight participants
demonstrated statistically significant improvements in intelligibility as measured using
percentage of understood words. These results are especially noteworthy since both studies by
Cannito et al. (2008) and Cannito et al. (2012) are somewhat biased against improved
intelligibility because of the introduction of pink noise during listening task.
Intrinsically connected to intelligibility is articulation. Improvements in articulation have
been observed using acoustic measures, including improved formant transition duration, rate, and
extent as well as increased vowel space (Fox et al., 2002; Fox et al., 2006). Increased amplitude
of movement of the articulators has also been noted (Ramig et al., 2004). Vowel articulation has
been of particular interest in the literature. Increased vowel space has been implicated as an
indicator of increased tongue movement and thus improved articulation. Sapir et al. (2010)
analyzed changes in vowel space using the vowel articulation index (VAI), logarithmically
scaled vowel space area (lnVSA), formant centralization ratio (FCR) and the ratio of the second
formant of /i/ to the second formant of /u/ (F2i/F2u). In their study, they found that all measures
showed significant improvement over the course of treatment, but FCR and F2i/F2u showed the
most significant changes. The next section explores the different kinds of vowel space area
metrics and their implication for articulation.
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Measuring Articulation: Vowel Space Area
There are many different ways to measure vowel articulation, each with benefits and
drawbacks. One common way of measuring improvements in vowel articulation is area of the
vowel space. Vowel space maps the geometric space created by the first and second formant (F1
and F2, respectively) in different vowels. F1 and F2 are related to tongue placement, with F1
decreasing as tongue height increases and F2 increasing as tongue advancement increases.
Measures of vowel space commonly use the corner vowels /i/, /u/, /ɑ/ and /æ/, which
theoretically encompass F1 and F2 extremes. Vowel space in dysarthric patients has been
measured in a variety of ways, including triangular vowel space area (tVSA) (Sapir et al., 2010;
Skodda et al., 2011), the area of the vowel quadrilateral (Higgins & Hodge, 2002), vowel
articulation index (VAI) (Skodda et al., 2011), the formant centralization ratio (FCR) (Sapir et
al., 2010) and the Tjaden method (McRae et al., 2002; Tjaden & Wilding, 2004). Each of these
methods varies in which vowels and formants they utilize, as well as their efficacy in measuring
changes in vowel articulation in patients with PD (see Table 1 in Appendix for details).
Skodda et al. (2011) found that VAI was better suited to detect impaired vowel
articulation in the PD population than tVSA. Sapir et al. (2010) created the formant
centralization ratio (FCR) to measure changes in vowels articulation specifically for the PD
population. In their study, FCR was found to differentiate between dysarthric and healthy speech
more successfully in comparison with other measures of vowel space, including VSA and
lnVSA. VAI and FCR, developed independently, are in fact inverses of each other and therefore
can be considered identical. This fact is supported by the similar results reported by Skodda et
al. (2011) and Sapir et al. (2010) that show that VAI and FCR are better suited to detect vowel
articulation impairment in individual with PD.
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In their study of intelligibility in normal speakers, Bradlow, Torretta, and Pisoni (1996)
found that although tVSA was larger in the most intelligible speaker versus the least intelligible
speaker, there was no correlation between tVSA and intelligibility. Rather, they found that
vowel space dispersion (VSD) showed moderate correlation with intelligibility, suggesting that
VSD may be a more reliable measure of intelligibility than tVSA. VSD is derived by first
calculating the center point in the vowel space by averaging all tokens of F1 (F1avg) and all
tokens of F2 (F2avg) such that the center point equals (F2avg, F1avg). The vector length (the
distance from the vowel to the midpoint) is then calculated, and these distances are averaged
together to obtain an overall VSD. Karlsson and van Doorn (2012) proposed a similar metric,
vowel formant dispersion (VFD). VFD utilizes a weighted midpoint, and the resulting distances
are not averaged into a single metric. Rather, the distances of each vowel are plotted and
considered individually, making this a descriptive if somewhat unwieldy metric. In contrast to
many other vowel space metrics, VSD and VFD can be adapted to consider vowels besides the
corner vowels /i/, /u/, /ɑ/ and /æ/, allowing for a more complete picture of the vowel space.
Though these metrics have not been well-studied in disordered populations, they appear worth
considering the richness of the data they can potentially yield.
In addition to varied ways of measuring vowel space, various materials have been used to
elicit vowels for analysis. Materials commonly used in previous literature include read sentences
(Cannito et al., 2006; Sapir et al., 2007; Sapir et al., 2010), read narrative passages (McRae et al,
2002; Tjaden & Wilding, 2004) and single words in isolation (Higgins & Hodge, 2002).
Connected speech yields more naturalistic results than sustained phonation or single words and is
thus more desirable for drawing conclusions that can be safely generalized. However,
monologue and conversation are problematic as they do not provide for consistent phonetic
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context and are prone to prosodic variations that make them difficult to analyze. Read passages
and sentences provide a compromise between consistency and utility. Sentences and passages
are still subject to prosodic variation, but uniformity between participants is more likely since all
participants read the same material.
Though vowel space area has been used in previous studies to draw conclusions about
changes in articulation following LSVT, there are variety of factors that require further
exploration. It has been hypothesized that changes in vowel articulation can be attributed to
improvements tongue placement, particularly in amplitude of movement. Vowel space has
typically been attributed to changes in articulation, but phonatory factors may interact with
formant determination such that changes in phonation and articulation are confounded. Since
there are well-reported changes in vocal quality following LSVT, this is a potentially important
consideration. The remainder of this chapter will review these issues in more detail by grouping
them in two areas of consideration: phonatory factors and challenges of formant measurement.
Phonatory Factors and Vowel Articulation
First there is the interaction between phonatory factors and vowel articulation. In a study
involving patients with idiopathic Parkinson’s disease, Neel (2009) found that amplified
dysarthric speech was more intelligible than unamplified dysarthric speech, suggesting that the
articulated target was close enough to the correct category to be recognized when the speech
signal was amplified. She also found that loud speech was more intelligible than amplified
speech, suggesting that there are factors intrinsic to loud speech other than increased amplitude.
While improved tongue placement has been a commonly suggested factor, Neel also proposed
that decreased spectral tilt during the loud condition contributed to improved articulation. Steep
spectral tilt has long been associated with breathy vocal quality (Hanson, 1997), a common
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feature of parkinsonian voice and hypokinetic dysarthria (HKD). A decrease in spectral tilt—
that is, a return to a more typical spectral configuration—indicates an improvement in the
contribution of voice to intelligibility with no particular effect on tongue placement.
Changes in bandwidth could also account for improvement in the perception of vowel
quality. Breathy vocal quality is associated with increased bandwidth (Hixon, Weismer, & Hoit,
2008). According to Hixon et al. (2008), “When speech synthesizers are used to systematically
increase the bandwidth of vowel formants while maintaining constant formant frequencies,
listeners do not hear a change in vowel category. Rather, vowels are perceived as increasingly
‘muffled’” (p. 379). This calls into question precisely what perceptual studies of vowel
articulation are measuring. In their study, Sapir et al. (2007) rated changes in “vowel goodness”
from pre to post LSVT in patients with idiopathic Parkinson’s disease, where “vowel goodness”
was defined as “how well an uttered vowel is judged as an exceptionally good instance, or best
exemplar, of an intended vowel” (p. 902). Though patients who underwent LSVT showed
improvements in “vowel goodness,” this metric failed to differentiate between changes in vowel
category and vowel quality due to improvements in vocal quality (i.e., reduced breathiness).
Challenges of Formant Measurement
Since most measures of vowel articulation rely on formants, methods of formant
measurement are another challenge which must be considered. Many studies use linear
predictive coding (LPC) to extract formant frequencies, which can be prone to error given certain
conditions. According to Vallabha and Tuller (2000), large bandwidth can cause errors in rootsolving, which is integral to LPC’s estimation of formants. This is a particular concern for
analyzing breathy voices, a hallmark of HKD. Large bandwidth can also cause problems when
formants are close together such as in high front vowels (where F2 is high and close to F3) and

22

low back vowels (where F1 is high and close to F2). This could be problematic for vowel space
measures, since most rely on the corner vowels /i/ (high front) and/or /ɑ/ (low back).
The filter order is also important to consider in LPC. Many studies utilize a standardized
choice of filter order, which may not be appropriate for all voices or all vowels. For example,
back vowels, such as /u/ and /ɑ/ often need a higher order filter than front vowels (Vallabha &
Tuller, 2000). Since both of these vowels are often used in calculating VSA, incorrect estimation
of their formant frequencies can cause over- or under-estimation of VSA. An inappropriately
high filter order can cause the appearance of false formants, while an inappropriately low filter
order can smooth the spectrum, causing two formants to merge, creating a false formant that is in
fact the average of two formants. According to Vallabha and Tuller (2000), it may be necessary
to choose a different filter order for each person and each vowel, using the visual of the spectrum
to determine the appropriateness of the filter order.
Finally, the basic assumptions of LPC are violated in breathy voices. LPC models
assume resonances only and not anti-resonances (Kent & Read, 2002). Anti-resonances are
created by a resonator off the main resonator (as in a nasal such as /n/) or behind the source. In
breathy voices, the incomplete closure of the vocal folds results in an additional resonator: the
subglottal space. This introduces anti-resonances into the voice. Such a violation calls into
question the validity of LPC in breathy voices, and it also introduces an increase in the
bandwidth of F1 (Hanson, 1997).
In an effort to address these issues, four formant measurement methods were used to
understand if and to what degree these different methods are affected by phonatory qualities.
These methods were LPC with a fixed coefficient (LPCf), cepstrally-liftered spectrum (ceps),
cepstrally-liftered spectrum employing the Story-Bunton algorithm (S-B) (Story & Bunton,

23

2015) and human-guided interactive mode (HGIM). HGIM utilized the spectrum, the LPC
adjusted to conform to the spectrum, and a wide-band view of the spectrogram to locate the
center of F1 and F2. A variety of methods were used to compute vowel space, including: VAI
(Skodda et al., 2011), F2i/F2u (Sapir et al., 2007; Sapir et al., 2010), VFD (Karlsson & van
Doorn, 2012) calculated using the corner vowels (VFDc) and VFD calculated using corner and
lax vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/ (VFDa). The cepstrally-liftered spectrum was of interest
since it theoretically separates the source from the filter, therefore eliminating phonatory effects
on the formant measures (Story & Bunton, 2015). Formants extracted using LPCf, ceps, S-B and
HGIM were used to compute each vowel space.
The primary research question of this thesis addresses the possibility that observed
increases in vowel space area associated with LSVT therapy are confounded with the known
improvements in phonatory quality. As a working hypothesis, it is presumed that LSVT does
result in an increase in vowel space. This was assessed using a number of methods to explore
whether this increase is artefactual. Results from the LPCf and spectrum smoothed by cepstral
liftering were compared to HGIM. If LPC were vulnerable to phonatory factors, then the LPC
based formant values are expected to be more variable across samples particularly in the pre
sessions when phonation is less robust. The formants extracted using the ceps and S-B are
expected to be closer to the HGIM because the confounding effects of the harmonics have been
removed. Vowel space areas resulting from each method were inspected for purported increase
effects post treatment.
Secondarily, this thesis explored a variety of vowel space area metrics. VAI and F2i/F2u
were used in the interest of replicating previous studies of changes in vowel space following
LSVT. Since VAI and FCR are essentially identical, VAI was chosen because of its more
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common appearance in the literature than FCR. VFDc and VFDa were included because of their
ability to track changes in individual vowels and incorporation of multiple tokens of the same
vowel. VFDa in particular was used to observe how lax vowels are affected by LSVT, which
has not been studied.
Method
Participants
These data were obtained from a data set that was recorded in a larger study for the
Michael J. Fox Foundation for Parkinson’s Research. The first 10 subjects in sequence were
used for this study. Participants (age range 45-80 years) diagnosed with IPD and moderate to
severe hypophonia were recruited. Diagnosis was determined by a neurologist. Efforts were
made to recruit an equal number of male and female participants. Efforts were made to
distribute patients ethnically and racially in a distribution that is consistent with the
demographics of the Memphis area (62% African American or black, 34% white, 2% Asian, 1%
American Indian/Alaska Native, remaining 1% other race or races; 97% not Hispanic, 3%
Hispanic). Participants were optimally medicated. All participants were evaluated using the
Hoehn and Yahr Scale (1967) and the Unified Parkinson Disease Rating Scale (UPDRS). As
part of the measures for the larger study, other screening measures that were carried out included
a hearing screening, Edinburgh handedness inventory (Oldfield, 1971), mini-mental status
examination (Folstein, Folstein, & McHugh, 1975), and Beck Depression Inventory (Steer, Beck,
& Garrison, 1986). Only participants with no or mild cognitive impairment or depression were
included. All participants underwent an ENT screening and vocal fold examination; participants
with evidence of structural abnormalities or vocal fold hyperfunction were excluded. See Table
2 in Appendix for a complete list of exclusion criteria.
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Treatment
All participants received LSVT for one hour, four times per week for four weeks. Faceto-face therapy was administered by a speech language pathologist licensed by the American
Speech-Language Hearing Association (ASHA) and certified in LSVT. During the first week,
therapy consisted of four face-to-face sessions. During the second, third, and fourth weeks, the
participants completed two of the four therapy days per week using the LSVT Companion.
Therapy supported by the LSVT Companion has been found yield similar results as traditional
face-to-face therapy (Halpern et al., 2012). It should be noted that some participants also
received transcranial magnetic stimulation (TMS) as part of a larger study studying the effect of
pairing TMS with LSVT.
Procedures and Data Collection
Recording sessions were conducted on six different days. Two took place before
treatment (PRE1 and PRE2), two took place after treatment was completed (POST1 and POST2)
and two were completed three months after the conclusion of therapy (FU1 and FU2). The two
sessions for the pre-, post-, and follow-up conditions took place within a week of each other. As
part of a larger assessment protocol, carrier phrases (“Say ___ again”) were used in accordance
with previous studies of acoustic features (Cannito et al., 2006, Hanson, 1997). The CVC
syllables /bVd/, /gVd/, /dVd/, and /wVd/ were used with the vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/
and each carrier phrase was repeated four times.
Participants were instructed verbally and provided with written phrases. All words were
read to them prior to recording in order to ensure correct pronunciation. If the participant
mispronounced a word during recording, the word was repeated for them. All recordings were
made in a sound booth using a Countryman E6 Earset with an elongated boom to permit 7 cm
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mic to mouth distance calibrated for a flattened response. Recordings were digitized at a
sampling rate of 50 kHz1 using Kay Pentax Computer Speech Laboratory (CSL Model 4500).
The intensity of the speech signals was measured and recorded using a Radio Shack sound level
meter (Catalog no. 33-2055) at 30 cm.
Data Analysis
Only the /b/ tokens were considered in this study. The selection of only one phonetic
context was justified by the fact that phonetic context has not been shown to impact vowel
formants (Schouten & Pols, 1979). The /b/ tokens were chosen in order to minimize potential
coarticulation effects. The first two correctly pronounced tokens of each vowel were used for
analysis. This was to minimize the effects of fatigue due to repetition and provide the “best
exemplars” of each token. Data from PRE1, PRE2, POST1, and POST2 were analyzed to get a
richer sample of variation over time. Data was analyzed using a customized version of the
software program TF-32 (Milenkovic, 2016). A zoom level of approximately 500 ms and a
bandwidth of 400 Hz was used to optimize formant visualization. Given the dialectical variation
of some participants, the portion of the vowel that best represented the target vowel was
determined auditorily. For example, diphthongization, a common feature of Southern English,
renders some productions of /bɛd/ as /bejɛd/. Therefore, only the portion which matches the
target vowel auditorily were used. In cases where no auditory difference could be determined
1

One session (POST1 for Subject 1) was found to be recorded at a sampling rate of 44 kHz.

due to the brevity of the segment or insufficiently dramatic formant shifts, the portion where the
location of the formants best represented the theoretical expectations of the target vowel was
chosen. For example, the steady state where F1 and F2 were the lowest would have been
selected for the target vowel /u/. F1 and F2 were determined using four methods: HGIM, LPCf,
ceps, and S-B. The coefficient for LPC was left at the setting recommended by TF-32 in order to
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replicate previous studies.
The formants were used to compute the area of the vowel quadrilateral (Higgins &
Hodge, 2002), F2i/F2u (Sapir et al., 2007; Sapir et al., 2010), VAI (Skodda et al., 2011), VFDc,
and VFDa, based on VFD by Karlsson and van Doorn (2012). These measures, with the
exception of VFDa and VFDc, have been chosen in order to compare the results of this study
with previous studies. VFDa and VFDc were included to determine changes in individual
vowels and to assess the appropriateness of these metrics in dysarthric speech, which has not yet
been explored.
Results
Before proceeding to presentation of results, this section begins with a review of the
study purposes in terms of measurement strategies and vowel space metrics. The research
questions of this study involved an attempt to replicate the study by Sapir et al. (2010), which
showed an increase in vowel space from pre to post LSVT. Human-guided interactive mode
(HGIM) was used as the gold standard of this study against which the validity of other formant
measurement approaches could be assessed. Considering the possibility that measurement issues
conspired with phonatory factors to create a confound for Sapir et al.’s methods, LPC with a
fixed coefficient (LPCf) was used as a basis of comparison. Minor adjustments to the LPC
coefficient were made by Sapir et al. (J. Spielman, personal communication, June 1, 2016);
however, of the formant measurement methods employed in this study, LPCf afforded the best
opportunity to assess the phonatory confound question and most closely approximated the
methods of Sapir et al. The cepstrally-liftered spectrum methods, ceps and S-B, were intended as
exploratory measures to assess the appropriateness of these methods for use with dysarthric adult
speakers since previous applications have only been with young children or modeled data (Story
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& Bunton, 2015, Story & Bunton, 2015, May).
A variety of vowel space metrics were considered as well. The vowel articulation index
(VAI) and F2i/F2u were selected for comparison with Sapir et al.’s (2010) previous study.
Though that study used the formant centralization ratio (FCR), VAI (simply the inverse of FCR)
was deemed an equivalent metric and is more commonly found in subsequent literature
concerning vowel space assessments in the PD population (Rusz et al., 2013; Spielman et al.,
2011). The area of the vowel quadrilateral (Higgins & Hodge, 2012) was selected as a standard
measure of VSA and because of its inclusion of all four corner vowels, /i/, /u/, /æ/, and /ɑ/. The
vowel formant dispersion (VFD) (Karlsson & van Doorn, 2012) calculated using the four corner
vowels /i/, /u/, /æ/, and /ɑ/ (VFDc) was examined for its ability to incorporate multiple tokens of
each vowel. Similarly, VFD (Karlsson & van Doorn, 2012) calculated using /i/, /u/, /ʌ/, /ɛ/, /æ/,
and /ɑ/ (VFDa) was examined for its ability to incorporate multiple tokens of each vowel as
while as its use of a wider variety of vowels. Vector lengths had not typically been combined
into a single metric by the developers of this method (F. Karlsson, personal communication, May
31, 2016), therefore, VFDc and VFDa were utilized in two ways. First, the average vector length
of all the vowels was calculated to determine whether the average vector length increased from
pre to post treatment. Secondly, the vector lengths of the individual vowels were compared pre
to post treatment to determine if there were any changes in the individual vowels.
Reliability of formant measures was assessed by having another rater reanalyze 20% of
the formant measures for all formant measurement methods (HGIM, LPCf, ceps, and S-B). An
attempt was made to distribute the reanalyzed samples evenly across participants, pre or post
sessions, and vowels. Highest priority was given to distribution across participants. Distribution
across pre and post sessions was the second consideration. Distribution across vowels was given
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the lowest priority. A Pearson product moment correlation was performed on all data. For
HGIM, the correlation coefficient was 0.93 for F1 and 0.96 for F2. For LPCf, the correlation
coefficient 0.93 for F1 and 0.90 for F2. For ceps, the correlation coefficient was 0.80 for F1 and
0.94 for F2. For S-B, the correlation coefficient was 0.89 for F1 and 0.96 for F2. The average
difference between raters was computed by calculating the difference between each formant
measure and averaging the differences. For HGIM, the average difference was -20.88 Hz for F1
and -15.70 Hz for F2. For LPCf, the average difference was 5.70 Hz for F1 and -3.18 Hz for F2.
For ceps, the average difference was 6.21 Hz for F1 and -56.50 Hz for F2. For S-B, the average
difference was 2.49 Hz for F1 and -45.18 Hz for F2. The standard error of these differences was
computed for all data. For HGIM, the standard error was 5.95 Hz for F1 and 13.16 Hz for F2.
For LPCf, the standard error was 5.28 Hz for F1 and 21.85 Hz for F2. For ceps, the standard
error was 9.37 Hz for F1 and 17.53 Hz for F2. For S-B, the standard error was 7.22 Hz for F1
and 14.12 Hz for F2. Reliability measure results are summarized in Table 3 in Appendix.
Repeated measures analysis might have been appropriate for a larger number of
observations (as cited in Sapir et al. 2010); however, due to the size of the available pool for this
study, the VSA metrics yielded only 10 observations per session. Visual inspection revealed
high variability across trials, regardless of formant measurement method, and treatment effects
were not substantially greater than trial variability. It appeared, therefore, that statistical analysis
was inappropriate for this data set so results will currently be examined graphically and
numerically. Figures1 through 5 in Appendix show trial and treatment results, with each
numerated figure depicting the results from one vowel space metric. Within each numerated
figure, each lettered set represents a given formant measurement method. Three graphs appear
within each of these sets: PRE1 to PRE2 differences, POST1 to POST2 differences, and
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treatment effects depicted as the differences between pre and post averages.
Graphical Presentation of Findings
VAI. VAI, utilized by Sapir et al. (2010), was calculated using the formant measurement
methods HGIM, LPCf, ceps, and S-B. The graphical results by subject are presented in Figure
1a through 1d in Appendix, with the lettered set representing the different formant measurement
methods. Visual inspection across treatment revealed no consistent increase or decrease in VAI.
By visual inspection of the data, treatment effects did not appear to be any larger than trial-totrial variability. Individual increases or decreases across treatment did not appear to exceed
increases or decreases across trials.
F2i/F2u. F2i/F2u, utilized by Sapir et al. (2010), was calculated using the formant
measurement methods HGIM, LPCf, ceps, and S-B. The graphical results by subject are
presented in Figure 2a through 2d in Appendix, with the lettered set representing the different
formant measurement methods. Visual inspection across treatment revealed no consistent
increase or decrease in F2i/F2u. By visual inspection of the data, treatment effects did not
appear to be any larger than trial-to-trial variability. Individual increases or decreases across
treatment did not appear to exceed increases or decreases across trials.
Area of the vowel quadrilateral. The area of the vowel quadrilateral, which includes
the four corner vowels /i/, /u/, /æ/, and /ɑ/, was calculated using the formant measurement
methods HGIM, LPCf, ceps, and S-B. The graphical results by subject are presented in Figure
3a through 3d in Appendix, with the lettered set representing the different formant measurement
methods. Visual inspection revealed no general trend of increase or decrease across treatment.
By visual inspection of the data, treatment effects did not appear to be any larger than trial-totrial variability.

Individual increases or decreases across treatment did not appear to exceed
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increases or decreases across trials.
VFDa. The vector lengths for each of the vowels /i/, /u/, /ʌ/, /ɛ/, /æ/, and /ɑ/ were
calculated using the formant measurement methods HGIM, LPCf, ceps, and S-B. These lengths
were then averaged to yield an average vector length for the vowel space for each trial, PRE1,
PRE2, POST1, and POST2. These values were then graphed in the same manner described
above. The graphical results by subject are presented in Figure 4a through 4d in Appendix, with
the lettered set representing the different formant measurement methods. Visual inspection
revealed no general trend of increase or decrease across treatment. By visual inspection of the
data, treatment effects did not appear to be any larger than trial-to-trial variability. Individual
increases or decreases across treatment did not appear to exceed increases or decreases across
trials.
To determine whether there was any significant change in the vowels that was not
reflected in the average of the vectors, the individual vowel vector lengths yielded by HGIM
were also examined. For each vowel, the vector lengths observed in the pre-treatment sessions
were compared graphically to those of the post-treatment sessions. The results are summarized
in Figure 6 in Appendix. A preliminary examination of the data revealed no significant change
in these gold-standard measures, so the examination was deferred for the other formant
measurement methods.
VFDc. The vector lengths for each of the corner vowels /i/, /u/, /æ/, and /ɑ/ were
calculated using the formant measurement methods HGIM, LPCf, ceps, and S-B. These lengths
were then averaged to yield an average vector length for the vowel space for each trial, PRE1,
PRE2, POST1, and POST2. These values were then graphed in the same manner described
above. The graphical results by subject are presented in Figure 4a through 4d in Appendix, with
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the lettered set representing the different formant measurement methods. Visual inspection
revealed no general trend of increase or decrease across treatment. By visual inspection of the
data, treatment effects did not appear to be any larger than trial-to-trial variability. Individual
increases or decreases across treatment did not appear to exceed increases or decreases across
trials.
Numerical Presentation of Findings
The results were also summarized numerically to corroborate the graphical results. To
determine whether treatment effects exceeded trial variability in this regard, the ranges of the pre
and post-trial differences and the treatment differences were calculated for each metric and
organized by formant measurement method. The ranges of the pretrial differences were
determining by calculating the subtracting the PRE1 metric value from the PRE2 metric value
for each subject. The pretrial differences were ordered numerically to determine the minimum
and maximum and the range was calculated by subtracting the minimum from the maximum.
The same process was repeated for the post trial difference range. Treatment differences were
computed by subtracting the PRE2 values from the POST1 values, since this difference could
most reasonably be expected to show treatment effects. These differences were then ordered
numerically and the range was calculated by subtracting the minimum from the maximum.
Results are summarized in Table 4 in Appendix.
A review of Table 4 shows that the treatment range exceeded the pre and post-trial ranges
for all metrics when calculated using HGIM. The treatment range did not exceed the trial ranges
for any metric using LPCf. For ceps, only VFDa and VFDc had treatment ranges that exceeded
the trial ranges. The area of the vowel quadrilateral and VFDc calculated using S-B had
treatment ranges that exceeded the trial ranges. In the cases where the treatment range exceeded
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the trial ranges, the treatment ranges were not substantially larger than the trial differences. This
supports the initial conclusion that treatment effects did not significantly exceed trial differences.
While Table 4 provides information on trial variability versus treatment differences, it
gives very little information about the direction and magnitude of treatment differences. To
determine whether any appreciable increases or decreases were observed from pre to post
treatment, the means for each vowel space metric were computed both pre and post therapy. The
means for the pre vowel spaces were computed by averaging the vowel spaces across subjects
for both the PRE1 and PRE2 sessions. This was repeated for the average post vowel spaces.
The mean difference was computed by subtracting the average pre vowel space from the average
post vowel space. The results are summarized in Table 5.
An examination of Table 5 supports the initial conclusion that the average post vowel
space values did not appreciably exceed the average pre vowel space values. A slight decrease
was noted for all vowel spaces calculated using HGIM except for F2i/F2u which showed no
change. For LPCf, VAI, F2i/F2u and the area of the vowel quadrilateral all showed a slight
decrease while VFDa and VFDc showed a moderate increase. For ceps, VAI showed a slight
decrease, F2i/F2u showed no change. Slight increases in the area of the vowel quadrilateral,
VFDa, and VFDc were noted for ceps. All vowel spaces calculated using S-B decreased slightly,
except F2i/F2u which showed no change.
Findings in Formant Measurement Methods
A central question in this study was whether phonatory factors influenced formant
measurement methods. Such an influence could potentially skew VSA measures, regardless of
metric used. Failure of this study to find significant changes in vowel space following LSVT
heightens the importance of possible interactions between formant measurement methods and
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phonatory factors. LPC was of particular interest because of its common use in previous VSA
studies, and its anticipated vulnerabilities to phonatory factors. It was expected that, if phonatory
factors were a confounding factor, there would be a high level of variability in the pre-treatment
sessions that decreased in the post-treatment sessions. It was conjectured that the measures
would be relatively more stable in the post condition due to the previously established phonatory
improvements that accompany LSVT.
To investigate this possibility, the standard deviations of each metric in the pre and post
condition were calculated and organized by formant measurement method. Results are
summarized in Appendix. Of all the formant measurement methods, LPCf had the greatest
standard deviation in both pre- and post-treatment sessions. Contrary to expectations, however,
the standard deviation of pre and post-trial differences saw no stabilization of LPCf. HGIM,
ceps, and S-B had relatively similar standard deviations and did not show a significant change
from pre to post. Therefore, the conjecture that measurement issues were confounded with
phonatory factors in previous findings of vowel space increase with LSVT was not supported.
Discussion
LSVT Treatment Effects
The initial premise of this thesis was that VSA would increase from pre to post LSVT.
However, the data do not support that there is any substantial change in VSA with LSVT. There
are many possible reasons why this study failed to replicate the results found by Sapir et al.
(2010). LPC was found to have the highest variability of all the formant measurement methods
examined in this study, and so prior results may have been affected by this variability. The
difference in materials used may also have influenced the results. The study by Sapir et al.
(2010) utilized read sentences while the current study used shorter carrier phrases. As such,
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there is the tenuous possibility that the shorter phrases yielded larger VSAs in the pre sessions,
leaving little room for improvement as a result of LSVT. Sapir et al.’s (2010) study included a
larger number of participants (19) than the current study but reported large effect sizes for the
formant centralization ratio (the inverse of VAI) and F2i/F2u. Therefore it does not appear the
difference in number of participants fully accounts for this study’s failure to replicate previous
results. Additionally, the treatment in this study was a combination of LSVT and transcranial
magnetic stimulation (TMS), while Sapir et al.’s (2010) study utilized LSVT only. Since the
researchers in this study are still blinded as to which participants received TMS versus sham
TMS, it is unknown if the addition of TMS had any effect on vowel space that would not have
been observed in Sapir et al.’s (2010) study. The current study also utilized the LSVT
Companion (Halpern et al., 2012), while Sapir et al. (2010) did not. Therapy supported by the
LSVT Companion has been shown to be comparable to traditional face-to face therapy.
To determine whether there was a common factor between subjects who did show an
increase in vowel space area following LSVT, two subjects were examined. Subjects 1 and 4,
showed a consistent increase across many, but not all, of the VSA metrics as based on all
measurement methods. Subject 4 showed a stronger tendency to increase, with a very slight
decrease in the area of the vowel quadrilateral as calculated by HGIM and LPCf. She was noted
to consistently demonstrate the largest vowel space across methods, metrics, and pre- vs. posttreatment sessions. Though Subject 1’s increases were generally weaker than Subjects 4’s, he
did show consistent increases across all metrics and methods except for VAI calculated with
LPCf, and the F2i/F2u ratio calculated with LPCf. In both these exceptions, the decrease was
noted to be very slight. In contrast to Subject 4 however, Subject 1 was noted to be on the lower
end—if not the lowest—on all metrics. The results of these two participants suggest that there
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are some people for whom LSVT does lead to an increase in VSA, though it is difficult to
conclude whether a common factor led to increased VSA in these participants and not the others.
To determine how specific vowels were affected in Subjects 1 and 4, the individual
vowel vector lengths were examined. Figure 7 in Appendix shows the pre to post change in
vector lengths for each vowel for Subjects 1 and 4.

Subject 4 showed moderate increases in

/æ/, /i/, and /u/ and a slight decrease in /ɑ/ while remaining approximately the same for /ɛ/ and
/ʌ/. Overall, the data support the observation of a modest increase in VSA for Subject 4.
Specifically, the vectors for the front vowels /i/ and /æ/ increased suggesting more forward
positioning of the tongue post-treatment. Additionally, the expansion of /i/ and /u/ as high
vowels and /æ/ as a low vowel support the notion of greater range in the size of oral constriction.
Subject 1 showed moderate vector length increases for /æ/, /i/, and /u/ and moderate decreases
for /ɑ/, /ʌ/. The vector length of /ɛ/ remained approximately the same. The decrease in vector
length for /ɑ/ may explain why he showed weaker increases in the various VSA metrics than
Subject 4. Based on the results of at least these two subjects, it is possible that /i/ and /u/ are the
vowels most likely to benefit from LSVT, explaining why VSA metrics that include these two
vowels are more likely to show increases than those that employ others.
Since Table 4 showed that most vowel space metrics had a greater treatment range than
trial range, this may initially lead to the mistaken impression that a substantial change due to
treatment took place. However, since Table 4 only includes the range of treatment differences, it
cannot be used to make conclusions about direction or magnitude of overall treatment effects.
The wider range seen in treatment differences versus pre and post-trial ranges can be accounted
for by the fact that some participants showed an increase in vowel space metric values while
others showed a decrease. This is corroborated by Figures 1 through 5, which show that the
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participants varied widely in the magnitude and direction of changes over treatment. A better
measure of treatment effects is Table 5, which summarizes the mean pre and post vowel space
metric values, and the signed difference of these averages. Table 5 shows that changes in vowel
space metric values varied slightly in most cases and that the direction of this change was also
inconsistent and highly influenced by the formant measurement method. The only metrics that
showed a moderate increase were VFDa and VFDc calculated using LPCf. This change can
most likely be accounted for by the wide variability associated with LPCf.
Formant Measurement Methods
The possible influence of phonatory factors on the various formant measurement methods
was a question of interest in this study. If LPC were influenced by phonatory factors, it was
expected that LPC with a fixed coefficient (LPCf) would be relatively more stable in the post
condition. By contrast, ceps and S-B, theoretically independent of phonatory factors, were
hypothesized to yield formants that were closer to HGIM. LPC was not found to be more stable
in the post condition as the standard deviation of the trial differences did not appear to decrease
from the pre to post condition (see Table 5 in Appendix). Therefore LPC is likely not influenced
so much by phonatory factors as initially supposed. However, LPCf was noted to have a greater
variability than any of the other measures, implying that it was the least stable of the four
measurement methods explored. The variability of ceps and S-B were comparable to those of
HGIM, tentatively supporting the claim that ceps and S-B are uninfluenced by phonatory factors.
Another methodological goal of this thesis was to examine the potential errors associated
with keeping LPC at a fixed coefficient based on the sampling rate. In this study, LPCf was
found to have misidentified the appropriate formant on 35 occasions and to have merged
formants on 13 occasions for a total of 48 conspicuous errors, or a total of 10% of the vowels.
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In the course of the investigation, it was noted that these errors were not evenly distributed
across vowels. This was of potential importance due to the reliance of some vowel space metrics
on a limited set of vowels. The vowels most prone to formant misidentification were /u/ and /ɑ/,
while the vowel most likely to suffer from formant merging was /i/. Formant were misidentified
in /u/ on 15 out of 80 instances, or 18.8% of the time. Formant were misidentified in /ɑ/ on 13
out of 80 occasions, or 16.3% of the time. Formants were misidentified or merged 14 out of 80
times for the vowel /i/, or 17.5% of the time. A complete breakdown of errors by vowel can be
found in Table 7 in Appendix. Overall, the errors associated with LPCf were generally
concentrated in the vowels /i/, /u/, and /ɑ/. This is especially important because these vowels are
the ones most typically associated with VSA metrics, including the vowel articulation index
(VAI), F2i/F2u, and area of the vowel quadrilateral. Several metrics, such as VAI and F2i/F2u,
rely solely on these vowels. Inaccuracy in the measurement of these formants can lead to
inaccurate VSA values.
LPC was not the only formant measurement method prone to errors in correct formant
identification. To appropriately locate and differentiate formants, it was often necessary to
adjust the two cepstrally-liftered spectrum methods, ceps and S-B, by adjusting the time-based
liftering coefficient. Both ceps and S-B were most prone to error in the form of merged
formants on the vowels /i/ and /ɑ/. Since adjustment could generally resolve this issue, both ceps
and S-B appear to have value as a guide for formant location in conjunction with other methods.
However, based on the prevalence of errors in LPC, ceps and S-B, it is not appropriate to use any
of these methods as an automated formant finder and human judgment is indispensable in
accurate formant location.
LSVT has been proposed to affect a variety of dimensions of speech. By failing to
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replicate the results of previous studies, this study calls into question claims that LSVT leads to
increased vowel space. This study has raised a variety of methodological questions and
highlighted the importance of thoughtful selection of VSA metric and formant analysis.
Automated formant measurement methods are prone to significant error that can lead to
erroneous results. It is clear that further study is required to understand what—if anything—is
occurring in the area of vowel articulation as a result of LSVT.
Areas of Further Study
One area of further study that could be addressed is changes in F1 and F2 for individual
vowels as a result of LSVT. Since all VSA metrics, with the exception of F2i/F2u, utilized both
F1 and F2, it is possible that important information about the individual formants was lost.
Further analysis of the data to explore changes in individual formants could reveal a general
trend of expansion in one dimension that was mitigated by lack of change in the other. It would
also be interesting to compare the changes in vowel space observed in this study with other
acoustic measures such as changes in loudness and perceptual measures such as changes in voice
quality. This might help shed light on why some participants, such as Subjects 1 and 4, showed
a general increase in vowel space while others did not. Since this study utilized TMS in addition
to LSVT, the revelation of which participants received TMS versus sham TMS might also clarify
how TMS impacted the efficacy of therapy.
The three-month follow-up sessions could also be analyzed, though their value is
questionable in light of this study’s apparent failure to find treatment effects. Another area of
interest would be to replicate this study with read sentences instead of carrier phrases to more
closely replicate the study by Sapir et al. (2010) to control for possible ceiling effects introduced
by differences in materials. Finally, though LPC with a fixed coefficient was found to introduce
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significant error in formant measurement, it would be valuable to know how well LPC adjusted
to fit the spectrum would agree with HGIM. Answers to these questions would go a long way to
enhancing our understanding of the relationship between LSVT and vowel space.
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speech disorders in children and adults (3rd Ed.). Austin: PRO-ED Inc.
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Table 1
Vowel Space Metrics
Measure

Area of vowel
quadrilateral

Algorithm

Citation

Area of an irregular quadrilateral = 0.5 × ([𝐹𝐹2𝑖𝑖 × 𝐹𝐹1æ +
𝐹𝐹2æ × 𝐹𝐹1𝑎𝑎 + 𝐹𝐹2𝑎𝑎 × 𝐹𝐹1𝑢𝑢 + 𝐹𝐹2𝑢𝑢 × 𝐹𝐹1𝑖𝑖] − [𝐹𝐹1𝑖𝑖 × 𝐹𝐹2æ +
𝐹𝐹1æ × 𝐹𝐹2𝑎𝑎 + 𝐹𝐹1𝑎𝑎 × 𝐹𝐹2𝑢𝑢 + 𝐹𝐹1𝑢𝑢 × 𝐹𝐹2𝑖𝑖])

Formant
centralization
ratio (FCR)

𝐹𝐹2𝑢𝑢 + 𝐹𝐹2𝑎𝑎 + 𝐹𝐹1𝑖𝑖 + 𝐹𝐹1𝑢𝑢
𝐹𝐹2𝑖𝑖 + 𝐹𝐹1𝑎𝑎

�𝐿𝐿𝐿𝐿𝐿𝐿 × (𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿)(𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿)(𝐿𝐿𝐿𝐿𝐿𝐿 − 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿)
Logarithmically Where 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 = �(𝐿𝐿𝐿𝐿𝐿𝐿1𝑖𝑖 − 𝐿𝐿𝐿𝐿𝐿𝐿1𝑢𝑢)2 + (𝐿𝐿𝐿𝐿𝐿𝐿2𝑖𝑖 − 𝐹𝐹2𝑢𝑢)2
𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 = �(𝐿𝐿𝐿𝐿𝐿𝐿1𝑖𝑖 − 𝐿𝐿𝐿𝐿𝐿𝐿1𝑎𝑎)2 + (𝐿𝐿𝐿𝐿𝐿𝐿2𝑖𝑖 − 𝐹𝐹2𝑎𝑎)2
scaled vowel
space area
𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 = �(𝐿𝐿𝐿𝐿𝐿𝐿1𝑎𝑎 − 𝐿𝐿𝐿𝐿𝐿𝐿1𝑢𝑢)2 + (𝐿𝐿𝐿𝐿𝐿𝐿2𝑎𝑎 − 𝐹𝐹2𝑢𝑢)2

(LnVSA)

𝐿𝐿𝐿𝐿𝐿𝐿 =

𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿+𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿+𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿
2

47

Task

Higgins &
Hodge (2002)

Single
words

Sapir, Ramig,
Spielman, & Fox
(2010)

Reading
sentences

Sapir, Ramig,
Spielman, & Fox
(2010)

Reading
sentences

Notes
Significantly
smaller area for
children with
dysarthria than
age-matched
controls
Differentiated
between
dysarthric
speakers with
PD and healthy
controls; not
sensitive to
gender effects
Did not
completely
differentiate
between
individuals with
dysarthria and
healthy controls

Table 1 (Continued)
Vowel Space Metrics
Measure

Ratio of F2/i/
to F2/u/
(F2i/F2u)

Tjaden
Method

Triangular
Vowel Space
Area (tVSA)

Algorithm

𝐹𝐹2𝑖𝑖
𝐹𝐹2𝑢𝑢

Bisecting vowel quadrilateral into two triangles,
calculating area of each triangle, and summing
triangles to get an estimation of the quadrilateral

Citation

Task

Sapir, Spielman,
Ramig, Story &
Fox (2007)

Reading
sentences

Sapir, Ramig,
Spielman, & Fox
(2010)

Reading
sentences

McRae, Tjaden,
& Schoonings
(2002)

Reading
Farm
passage

Tjaden & Wilding
(2004)
Reading
passage

Bradlow,
Torretta, & Pisoni
0.5 × ([𝐹𝐹2𝑢𝑢 + 𝐹𝐹2𝑖𝑖] × [𝐹𝐹1𝑢𝑢 − 𝐹𝐹1𝑖𝑖] − [𝐹𝐹2𝑎𝑎 + 𝐹𝐹2𝑢𝑢] × (1996)
[𝐹𝐹1𝑎𝑎 − 𝐹𝐹1𝑢𝑢] − [𝐹𝐹2𝑎𝑎 + 𝐹𝐹2𝑖𝑖] × [𝐹𝐹1𝑎𝑎 − 𝐹𝐹1𝑖𝑖])
Skodda, Visser &
Schlegel (2010)
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Reading
sentences

Reading
sentences

Notes
Differentiated between
individual with PD and
healthy controls
Differentiated between
individuals with PD
and healthy controls;
not sensitive to gender
effects
Significantly smaller
area for participants
with PD than age- and
sex-matched controls
Significantly smaller
area for participants
with PD and MS and
neurologically normal
controls
No positive correlation
between tVSA and
intelligibility in normal
speakers.
Only reduced in male
PD speakers

Table 1 (Continued)
Vowel Space Metrics
Measure
Vowel
Articulation
Index (VAI)

Vowel
Formant
Dispersion
(VFD)

Vowel Space
Area (VSA)

Vowel Space
Dispersion
(VSD)

Algorithm
𝐹𝐹2𝑖𝑖 + 𝐹𝐹2𝑎𝑎
𝐹𝐹1𝑖𝑖 + 𝐹𝐹1𝑢𝑢 + 𝐹𝐹2𝑢𝑢 + 𝐹𝐹2𝑎𝑎

Vector length=�(𝐹𝐹1−𝐹𝐹1𝑚𝑚 )2 +(𝐹𝐹2 − 𝐹𝐹2𝑤𝑤𝑤𝑤 )2
Where F1m is the average of all F1 tokens and F2wm is
the weighted average of all F2 tokens such that all F2
tokens associated with F1 values greater than F1m are
excluded.

𝐴𝐴𝐴𝐴𝐴𝐴[𝐹𝐹1𝑖𝑖×(𝐹𝐹2𝑎𝑎−𝐹𝐹2𝑢𝑢)+𝐹𝐹1𝑎𝑎×(𝐹𝐹2𝑢𝑢−𝐹𝐹2𝑖𝑖)+𝐹𝐹1𝑢𝑢×(𝐹𝐹2𝑖𝑖−𝐹𝐹2𝑎𝑎)]
2

Vector length=�(𝐹𝐹1−𝐹𝐹1𝑚𝑚 )2 +(𝐹𝐹2 − 𝐹𝐹2𝑚𝑚 )2
Where F1m is the average of all F1 tokens and F2m is
the average of all F2 tokens. Vector lengths are
averaged to yield a single number

49

Citation

Task

Skodda, Visser &
Schlegel (2010)

Reading
sentences

Karlsson & van
Doorn (2012)

Single
words

Notes
Reduced values in male
and female PD
speakers; more
sensitive to mild
dysarthria than tVSA
In normal speakers,
VFD less prone to
producing Type I or
Type II errors than
VAI, FCR, and other
vowel space metrics

Sapir, Ramig,
Spielman, & Fox
(2010)

Reading
sentences

No significant
difference between
participants with PD
and neurologically
healthy controls

Bradlow,
Torretta, & Pisoni
(1996)

Reading
sentences

Moderately correlated
with intelligibility in
normal speakers

Table 2
Additional Exclusion Criteria
History of drug abuse, neurological condition besides IPD, seizures, head trauma
Other current medical conditions, including brain damage, brain inflammation, heart disease,
pregnancy, uncorrected hearing loss
Medical implants, including metal objects implanted in head, ferrous metal filings in eye,
pacemaker, medication pump, cardiac lines
Current medications, including certain medications for depression or seizures
Advanced Parkinson’s Disease (stage V)
Score of greater than 19 on the Beck Depression Inventory
Score of less than 24 on Mini-Mental Status Examination
Have undergone LSVT within the last three years
Cannot read at 6th grade level
Cannot increase vocal loudness in sustained phonation on command by at least 3 dB SPL
Table 3
Summary of Reliability Data Organized According to Formant Measurement Method and
Formant
HGIM
F1
F2
Pearson’s r
Average
difference
Standard
error diffs

0.93

0.96

-20.88 -15.70
5.95

13.16

LPCf

Ceps

Ceps S-B
F1
F2

F1

F2

F1

F2

0.93

0.90

0.80

0.94

0.89

0.96

5.70

-3.18

6.21

-56.50

2.49

-45.18

5.28

21.85

9.37

17.53

7.22

14.12
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Table 4
Range of Pre- and Post-trial Differences versus Treatment Differences
HGIM

LPC fixed

Ceps

Ceps S-B

Pre

Post

Tx

Pre

Post

Tx

Pre

Post

Tx

Pre

Post

Tx

VAI

0.16

0.09

0.20

0.34

0.33

0.33

0.15

0.21

0.13

0.19

0.14

0.16

F2i/F2u

0.48

0.36

0.51

0.82

1.08

0.99

0.42

0.78

0.35

0.52

0.44

0.40

Area*

17.5

12.4

20.2

68.1

35.6

48.7

10.1

22.9

15.7

10.9

16.2

19.0

VFDc

126.0

89.3

149.4

405.6

137.0

192.3

143.7

100.0

153.3

139.6

109.1

155.0

VFDa

106.2

114.0

155.5

310.9

325.9

212.2

123.5

84.6

138.9

182.1

76.1

152.0

* × 104
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Table 5
Pre- and Post- Mean Values versus Mean Difference
HGIM

LPC fixed

Ceps

Ceps S-B

Pre

Post

Diff

Pre

Post

Diff

Pre

Post

Diff

Pre

Post

Diff

VAI

1.08

1.05

-0.03

1.06

1.01

-0.04

1.08

1.07

-0.01

1.08

1.06

-0.02

F2i/F2u

1.74

1.74

0.00

1.61

1.56

-0.05

1.77

1.77

0.00

1.79

1.79

0.00

Area*

24.2

22.5

-1.6

18.3

18.1

-0.2

22.4

22.7

0.2

24.1

23.2

-0.9

VFDc

454.0

448.5

-5.5

504.4

527.8

23.4

470.3

475.7

5.4

478.9

477.5

-1.5

VFDa

400.3

392.1

-8.3

445.1

483.9

38.9

400.0

407.3

7.3

420.2

418.4

-1.8

* × 104
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Table 6
Standard Deviation of Trial Differences
HGIM

LPC fixed

Ceps

Ceps S-B

Pre

Post

Pre

Post

Pre

Post

Pre

Post

VAI

0.05

0.03

0.10

0.12

0.04

0.05

0.05

0.04

F2i/F2u

0.14

0.12

0.25

0.37

0.12

0.21

0.13

0.12

Area*

5.4

3.6

18.0

11.7

3.7

5.8

4.4

4.6

VFDc

38.69

26.74

108.29

51.73

39.97

32.54

38.95

31.86

VFDa

31.83

31.73

87.69

88.56

37.71

28.48

47.20

30.67

* × 104
Table 7
Incidence of LPC Formant Identification Errors
ɛ

ʌ

u

i

æ

ɑ

Formants missed

0

4

15

3

0

13

Formants merged

2

0

0

11

0

0
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Pre

Post

Figure 1a. VAI calculated using HGIM as a function of treatment and trial differences
Pre

Figure 1b. VAI calculated using LPCf as a function of treatment and trial differences
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Post

Pre

Post

Figure 1c. VAI calculated using ceps as a function of treatment and trial differences
Pre

Figure 1d. VAI calculated using S-B as a function of treatment and trial differences
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Post

Pre

Post

3.0
2.5

F2i/F2u

2.0
1.5
1.0
0.5
0.0

Pre

Post

Treatment

Figure 2a. F2i/F2u calculated using HGIM as a function of treatment and trial differences
Pre

Figure 2b. F2i/F2u calculated using LPCf as a function of treatment and trial differences
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Post

Pre

Post

Figure 2c. F2i/F2u calculated using ceps as a function of treatment and trial differences
Pre

Post

Figure 2d. F2i/F2u calculated using S-B as a function of treatment and trial differences
Pre
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Post

Figure 3a. Area of vowel quadrilateral calculated using HGIM as a function of treatment and trial differences
Pre
Post

Figure 3b. Area of vowel quadrilateral calculated using LPCf as a function of treatment and trial differences
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Pre

Post

Figure 3c. Area of vowel quadrilateral calculated using ceps as a function of treatment and trial differences
Pre
Post

Figure 3d. Area of vowel quadrilateral calculated using S-B as a function of treatment and trial differences
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Pre

Post

Figure 4a. VFDa calculated using HGIM as a function of treatment and trial differences
Pre

Figure 4b. VFDa calculated using LPCf as a function of treatment and trial differences
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Post

Pre

Post

Figure 4c. VFDa calculated using ceps as a function of treatment and trial differences
Pre

Figure 4d. VFDa calculated using S-B as a function of treatment and trial differences
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Post

Pre

Figure 5a. VFDc calculated using HGIM as a function of treatment and trial differences
Pre

Figure 5b. VFDc calculated using LPCf as a function of treatment and trial differences
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Post

Post

Pre

Figure 5c. VFDc calculated using ceps as a function of treatment and trial differences
Pre

Figure 5d. VFDc calculated using S-B as a function of treatment and trial differences
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Post

Post

Figure 6. Comparison of pre to post LSVT vector lengths calculated using VFDa
Subject 1

Subject 4

Figure 7. Comparison of pre to post LSVT vector lengths calculated using VFDa in Subjects 1
and 4
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From: Beverly Jacobik (bjacobik) On Behalf Of Institutional Review Board
Sent: Wednesday, October 01, 2014 9:15 AM
To: Michael P Cannito (mcannito)
Subject: IRB Approval 3429

Hello,
The University of Memphis Institutional Review Board, FWA00006815, has reviewed and
approved your submission in accordance with all applicable statuses and regulations as well as
ethical principles.
PI NAME: Michael Cannito
CO-PI: Shalini, Narayana, Ph.D., Asim F. Choudhri, MD, Ronald F. Pfeiffer, MD, at UTHSC
PROJECT TITLE: Augmenting Treatment Effects of Voice Therapy in Parkinson’s Disease
FACULTY ADVISOR NAME (if applicable): n/a
IRB ID: #3429
APPROVAL DATE: 9/11/2014
EXPIRATION DATE: 8/6/2015
LEVEL OF REVIEW: Facilitated Review, UTHSC
RISK LEVEL DETERMINATION:No more than minimal
Please Note: Modifications do not extend the expiration of the original approval
Approval of this project is given with the following obligations:
1. If this IRB approval has an expiration date, an approved renewal must be in effect to
continue the project prior to that date. If approval is not obtained, the human consent
form(s) and recruiting material(s) are no longer valid and any research activities involving
human subjects must stop.
2. When the project is finished or terminated, a completion form must be completed and
sent to the board.
3. No change may be made in the approved protocol without prior board approval,
whether the approved protocol was reviewed at the Exempt, Exedited or Full Board level.
4. Exempt approval are considered to have no expiration date and no further review is
necessary unless the protocol needs modification.
Approval of this project is given with the following special obligations:

Pamela M. Valentine
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Interim Institutional Review Board Chair
The University of Memphis.
Note: Review outcomes will be communicated to the email address on file. This email should
be considered an official communication from the UM IRB. Consent Forms are no longer
being stamped as well. Please contact the IRB at IRB@memphis.edu if a letter on IRB
letterhead is required.
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THE UNIVERSITY OF TENNESSEE
Health Science Center
Institutional Review Board
910 Madison Avenue, Suite 600
Memphis, TN 38163
Tel: (901) 448-4824

5 August 2015

Shalini Narayana, PhD
UTHSC - COM - Peds - General Pediatrics
335 Le Bonheur Outpatient Center
51 N Dunlap Street
Memphis, TN 38105
Re: 14-03265-FB UM
Study Title: Augmenting Treatment Effects of Voice Therapy in Parkinson's Disease [Master
Protocol, dated 01/15/2014; revised 06/05/2015]

Dear Dr. Narayana:
On 08/05/2015, the UTHSC Institutional Review Board (IRB) reviewed your application to
continue your previously approved project, referenced above. The IRB has reviewed your
renewal application and determined that it complies with proper consideration for the rights and
welfare of human subjects and the regulatory requirements for the protection of human subjects.
Therefore, this letter constitutes approval of your renewal application, including main and
repository consent forms dated 07/07/2015 (stamped IRB approved 08/05/2015). The UTHSC
IRB stamped-approved consent forms must be used to enroll prospective subjects in the
study. Approval of this study will be valid from 08/05/2015 to 08/06/2016.
This study may not be continued until you receive re-approval from the institution(s) where
the research is being conducted.
In accord with 45 CFR 46.116(d), alteration of informed consent continues to be approved, with
the cover statement for telephone screening used in lieu of an informed consent interview. The
requirement to secure a signed consent form continues to be waived under 45 CFR 46.117(c)(2).
Willingness of the subject to participate constitutes adequate documentation of consent.
In addition, the request for waiver of HIPAA authorization to identify potential subjects for
recruitment continues to be approved. The waiver applies to the medical records of patients with
Parkinson’s disease from referring physicians and local support groups.
In the event that subjects are to be recruited using solicitation materials, such as brochures,
posters, web-based advertisements, etc., these materials must receive prior approval of the IRB.
Any revisions in the approved application must also be submitted to and approved by the IRB
prior to implementation. In addition, you are responsible for reporting any unanticipated serious
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adverse events or other problems involving risks to subject or others in the manner required by
the local IRB policy.
Finally, re-approval of your project is required by the IRB in accord with the conditions
specified above. You may not continue the research study beyond the time or other limits
specified unless you obtain prior written approval of the IRB.
Sincerely,

Signature applied by Holly A Herron on 08/05/2015 11:34:43 AM CDT

Holly A Herron, BA, CIM
IRB Administrator
UTHSC IRB

Terrence F Ackerman, PhD
Chairman
UTHSC IRB
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THE UNIVERSITY OF TENNESSEE
Health Science Center
Institutional Review Board
910 Madison Avenue, Suite 600
Memphis, TN 38163
Tel: (901) 448-4824

September 11, 2014

Shalini Narayana, PhD
UTHSC - COM - Peds - General Pediatrics
335 Le Bonheur Outpatient Center
51 N. Dunlap Street
Memphis, TN 38105
Re: 14-03265-FB UM
Study Title: Augmenting Treatment Effects of Voice Therapy in Parkinson's Disease [Master
Protocol, dated 1/15/2014]

Dear Dr. Narayana:
The IRB has received your written acceptance of and/or responses dated 09/10/2014 and 9/9/2014
to the provisos outlined in our correspondence of 9/10/2014 and 8/6/2014 concerning the
application for the above referenced project. The IRB has reviewed these materials and
determined that they comply with proper consideration for the rights and welfare of human
subjects and the regulatory requirements for the protection of human subjects. Therefore, this
letter constitutes full approval by the IRB of your application, Version 1.5 and the accompanying
documents:
 Master Protocol, dated 1/15/2014
 510K document, dated 9/29/2011
 Charite Clinical Statement, dated 10/31/2012
 Navigated Brain Stimulation Product Brochure, Version 1.0
 NexSpeech for NBS System Product Brochure, Version 1.0
 Flyer, dated 9/11/2014 (stamped IRB approved 9/11/2014)
 Recruitment Brochure, dated 9/9/2014 (stamped IRB approved 9/11/2014)
 Phone screening form, dated 9/9/2014
 Voice-related QOL, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Subject Information Sheet, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Screening Questionnaire for TMS Candidates-SN, dated 6/10/214 (stamped IRB approved
9/11/2014)
 MRI-TMS Metal Screening, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Mini Mental State Exam, dated 6/10/2014
 Medical History Screening, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Edinburgh Handedness Inventory, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Beck Depression Inventory, dated 6/10/2014 (stamped IRB approved 9/11/2014)
 Main Consent form, dated 9/11/2014 (stamped IRB approved 9/11/2014)
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Repository Consent Form, dated 9/11/2014 (stamped IRB approved 9/11/2014)

Approval of this study will be valid from 9/11/2014 to 8/6/2015.

This study may not be initiated until you receive approval from the institution(s) where the
research is being conducted.
The IRB has determined that the informed consent form, incorporating the authorization of
subjects to use their protected health information in research, complies with the federal privacy
regulations as specified in 45 CFR 160 and 45 CFR 164. In addition, in accord with 45 CFR
46.116(d), informed consent may be altered, with the cover statement of the telephone screening
used in lieu of an informed consent interview. The requirement to secure a signed consent form
is waived under 45 CFR 46.117(c)(2). Willingness of the subject to participate will constitute
adequate documentation of consent.
In addition, the request for waiver of HIPAA authorization for telephone screening is approved.
The waiver applies to the medical records of Parkinson’s Disease patients.
In the event that subjects are to be recruited using solicitation materials, such as brochures,
posters, web-based advertisements, etc., these materials must receive prior approval of the IRB.
Any revisions in the approved application must also be submitted to and approved by the IRB
prior to implementation. In addition, you are responsible for reporting any unanticipated serious
adverse events or other problems involving risks to subjects or others in the manner required by
the local IRB policy.
Finally, re-approval of your project is required by the IRB in accord with the conditions
specified above. You may not continue the research study beyond the time or other limits
specified unless you obtain prior written approval of the IRB.
Sincerely,

Signature applied by Margaret M Sularin on 09/11/2014 09:29:33 AM CDT

Signature applied by Terrence F Ackerman on 09/11/2014 09:33:35 AM CDT

Margaret M. Sularin, LMSW, RD, LDN, CCRP, CIM
Regulatory Specialist
UTHSC IRB
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Terrence F. Ackerman, Ph.D.
Chairman
UTHSC IRB
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